Abstract
An interstitial brachytherapy approach for gynecologic cancers is typically considered for patients with lesions exceeding 5 mm within tissue or that are not easily accessible for intracavitary applications. Recommendations for treating gynecologic malignancies with this approach are available through the American Brachytherapy Society, but vary based on available resources, staffing, and logistics. The intent of this manuscript is to share the collective experience of 3 academic centers that routinely perform interstitial gynecologic brachytherapy. Discussion points include indications for interstitial implants, procedural preparations, applicator selection, anesthetic options, imaging, treatment planning objectives, clinical workflows, timelines, safety, and potential challenges. Interstitial brachytherapy is a complex, high-skill procedure requiring routine practice to optimize patient safety and treatment efficacy. Clinics planning to implement this approach into their brachytherapy practice may benefit from considering the discussion points shared in this manuscript.
| Original language | English (US) |
|---|---|
| Journal | Seminars in Radiation Oncology |
| DOIs | |
| State | Accepted/In press - Jan 1 2019 |
Fingerprint
ASJC Scopus subject areas
- Oncology
- Radiology Nuclear Medicine and imaging
- Cancer Research
Cite this
Interstitial High-Dose-Rate Gynecologic Brachytherapy : Clinical Workflow Experience From Three Academic Institutions. / Prisciandaro, Joann I.; Zhao, X.; Dieterich, S.; Hasan, Y.; Jolly, S.; Al-Hallaq, H.
In: Seminars in Radiation Oncology, 01.01.2019.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Interstitial High-Dose-Rate Gynecologic Brachytherapy
T2 - Clinical Workflow Experience From Three Academic Institutions
AU - Prisciandaro, Joann I.
AU - Zhao, X.
AU - Dieterich, S.
AU - Hasan, Y.
AU - Jolly, S.
AU - Al-Hallaq, H.
PY - 2019/1/1
Y1 - 2019/1/1
N2 - An interstitial brachytherapy approach for gynecologic cancers is typically considered for patients with lesions exceeding 5 mm within tissue or that are not easily accessible for intracavitary applications. Recommendations for treating gynecologic malignancies with this approach are available through the American Brachytherapy Society, but vary based on available resources, staffing, and logistics. The intent of this manuscript is to share the collective experience of 3 academic centers that routinely perform interstitial gynecologic brachytherapy. Discussion points include indications for interstitial implants, procedural preparations, applicator selection, anesthetic options, imaging, treatment planning objectives, clinical workflows, timelines, safety, and potential challenges. Interstitial brachytherapy is a complex, high-skill procedure requiring routine practice to optimize patient safety and treatment efficacy. Clinics planning to implement this approach into their brachytherapy practice may benefit from considering the discussion points shared in this manuscript.
AB - An interstitial brachytherapy approach for gynecologic cancers is typically considered for patients with lesions exceeding 5 mm within tissue or that are not easily accessible for intracavitary applications. Recommendations for treating gynecologic malignancies with this approach are available through the American Brachytherapy Society, but vary based on available resources, staffing, and logistics. The intent of this manuscript is to share the collective experience of 3 academic centers that routinely perform interstitial gynecologic brachytherapy. Discussion points include indications for interstitial implants, procedural preparations, applicator selection, anesthetic options, imaging, treatment planning objectives, clinical workflows, timelines, safety, and potential challenges. Interstitial brachytherapy is a complex, high-skill procedure requiring routine practice to optimize patient safety and treatment efficacy. Clinics planning to implement this approach into their brachytherapy practice may benefit from considering the discussion points shared in this manuscript.
UR - http://www.scopus.com/inward/record.url?scp=85072540345&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85072540345&partnerID=8YFLogxK
U2 - 10.1016/j.semradonc.2019.08.001
DO - 10.1016/j.semradonc.2019.08.001
M3 - Article
C2 - 31727297
AN - SCOPUS:85072540345
JO - Seminars in Radiation Oncology
JF - Seminars in Radiation Oncology
SN - 1053-4296
ER -